Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Clin Cancer Res. 2014 Feb 11;20(5):1259–1273. doi: 10.1158/1078-0432.CCR-13-1664

Table III.

Effect of Nexrutine intervention on inflammation, fibrosis in BK5-Cox-2 mice.

Treatment Animal ID# Inflammation Fibrosis mPan 1A mPan 1B mPan 2 mPan 3
Control PK12 100 0 0
Control PK12 103 0 0
Control PK12 104 0 0
Control PK12 117 0 0
Control PK12 125 0 0
Control PK12 101 0.5+ 0.5+
Control PK12 102 0.5+ 0.5+ FOCAL
Control PK12 116 0.5+ 0.5+ Y
Control PK12 123 0.5+ 0.5+
Control PK12 124 0 0.5+
Control PK12 126 0 0.5+
Control PK12 127 0.5 0.5+
Control PK12 128 0.5+ 0.5+
Control PK12 114 0 0.5A
Control PK12 62 1+ 1+
Control PK12 63 1+ 1+
Control PK12 64 1+ 1+
Control PK12 80 1+ 1+
Control PK12 115 0.5+ 1+ FOCAL
Control PK12 66 2+ 2+ Y
Control PK12 78 1+ 2+ Y
Control PK12 91 0.5+ 2+
Control PK12 99 1+ 2+ Y
Nx PK12 86 0 0
Nx PK12 90 0 0
Nx PK12 119 0 0
Nx PK12 121 0 0
Nx PK12 129 0 0
Nx PK12 72 0.5+ 0.5+
Nx PK12 73 0.5+ 0.5+
Nx PK12 83 0 0.5+
Nx PK12 84 0.5+ 0.5+
Nx PK12 88 0.5+ 0.5+ Y
Nx PK12 89 0.5+ 0.5+
Nx PK12 118 0.5+ 0.5+ FOCAL
Nx PK12 120 0 0.5+
Nx PK12 122 0.5 0.5+
Nx PK12 130 0.5+ 0.5+
Nx PK12 131 0 0.5+
Nx PK12 74 1+ 1+
Nx PK12 77 1+ 1+
Nx PK12 85 0.5+ 1+ Y
Nx PK12 87 1+ 1+ Y
Nx PK12 133 1+ 1+ Y
Nx PK12 79 1+ 2+ Y
Nx PK12 132 3+ 3+ Y